• Publications
  • Influence
A68930: a potent agonist selective for the dopamine D1 receptor.
A68930, (1R,3S)-1-aminomethyl-5,6-dihydroxy-3-phenylisochroman HCl, is a potent (EC50 = 2.5 nM), partial (intrinsic activity = 66% of dopamine) agonist in the fish retina dopamine-sensitive adenylateExpand
  • 83
  • 6
Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.
The available evidence suggests that daily injections of selective dopamine (DA) D2 receptor agonists to DA depleted rats typically leads to behavioral sensitization, but the effects of repeatedExpand
  • 44
  • 4
Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
Recent electrophysiological findings have indicated that D1 dopamine (DA) receptor stimulation by SKF 38393 enables the inhibitory effects of the D2 receptor agonist quinpirole on nucleus accumbensExpand
  • 183
  • 2
Broad-band frequency characterization of double Y-branch nanojunction operating as room-temperature RF to DC rectifier
Room-temperature dc and broad-band high-frequency (HF) to dc conversion measurements of a double Y-branch junction (YBJ) are presented and discussed. Nonlinear dc characteristics of the devices atExpand
  • 21
  • 2
Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats
In this paper report the effects of peripheral (intraperitoneal, i.p.) and central (intracerebroventricular, i.c.v.) injection of selective cholecystokinin (CCK) receptor agonists on food intake inExpand
  • 39
  • 1
A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor.
A-69024 HBr, 1-(2-bromo-4,5-dimethoxybenzyl)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4- tetrahydroisoquinoline hydrobromide, is a selective antagonist of the dopamine D-1 receptor. A-69024 HBr shows anExpand
  • 30
  • 1
Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
A-77636 is a dopamine (DA) D1 receptor-selective agonist that was previously shown to elicit beneficial responses in animal models of Parkinson's disease (PD) (Kebabian et al.: Eur. J. Pharmacol.Expand
  • 37
  • 1
Differential effects of serotonergic and catecholaminergic drugs on ingestive behavior
The serotonergic agonists fenfluramine and fluoxetine and the catecholaminergic agonists amphetamine and phenylpropanolamine are well known to cause a reduction in intake in rats. In the studiesExpand
  • 28
  • 1
Rotation in response to selective dopamine receptor agonists in rats with electrolytic substantia nigra lesions.
Rats with unilateral, electrolytic substantia nigra (ESN) lesions were tested for rotation following systemic injections of the D1 dopamine receptor agonist SKF38393 or the D2 agonist quinpirole.Expand
  • 6
  • 1
A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey
The anorectic actions of cholecystokinin (CCK)-8 and of a selective CCK-A agonist, A-71623, were examined in CD1 mice, beagle dogs, and cynomolgus monkeys. A-71623 suppressed intakes in all speciesExpand
  • 31